World J Mens Health.  2015 Aug;33(2):103-108. 10.5534/wjmh.2015.33.2.103.

Chronic Prostatitis: A Possible Cause of Hematospermia

• Lee G

• KMID: 2032830
• DOI: http://doi.org/10.5534/wjmh.2015.33.2.103

Abstract

PURPOSE
While hematospermia is mainly caused by genitourinary inflammatory disorders, very few studies have been published on prostatitis-associated hematospermia (PAH) diagnosed using robust prostatitis evaluation methods. Therefore, we have evaluated the incidence of PAH by using systematic methods for evaluating prostatitis.
MATERIALS AND METHODS
We evaluated 37 hematospermia patients from a single hospital over the last five years. We classified the patients into PAH versus hematospermia without any evidence of prostatitis (HWP) by using a NIH-Chronic Prostatitis Symptom Index questionnaire and expressed prostatic secretion studies.
RESULTS
The mean age was 55.89+/-14.87 years, and the patients were grouped into two groups: one group had 12 HWP patients and the other 25 PAH patients. PAH patients were further sub-classified: chronic bacterial prostatitis (3 patients), chronic nonbacterial prostatitis (10 patients), prostadynia (7 patients), and asymptomatic prostatitis (5 patients). We found Enterococcus faecalis in the three chronic bacterial prostatitis patients. We could not find any statistically significant difference between the PAH and the HWP groups in terms of the age interval, serum prostate-specific antigen level, and prostate volume. Even though there was no statistically significant difference in the items about urination between the two groups, we found a statistically significant difference in the quality of life (QoL) impact for the patients in this study.
CONCLUSIONS
Two-thirds of the hematospermia patients were associated with some evidence of prostatitis. Further, the patients with PAH revealed poor QoL compared with the patients with HWP. Therefore, we must evaluate the presence of prostatitis in hematospermia patients and alleviate the prostatitis-associated symptoms to improve their QoL.

Keyword

Hematospermia; Prostate; Prostatitis

MeSH Terms

Enterococcus faecalis
Hemospermia*
Humans
Incidence
Prostate
Prostate-Specific Antigen
Prostatitis*
Quality of Life
Urination
Prostate-Specific Antigen

Reference

1. Ng YH, Seeley JP, Smith G. Haematospermia as a presenting symptom: outcomes of investigation in 300 men. Surgeon. 2013; 11:35–38.

2. Ahmad I, Krishna NS. Hemospermia. J Urol. 2007; 177:1613–1618.

3. Szlauer R, Jungwirth A. Haematospermia: diagnosis and treatment. Andrologia. 2008; 40:120–124.

4. Stefanovic KB, Gregg PC, Soung M. Evaluation and treatment of hematospermia. Am Fam Physician. 2009; 80:1421–1427.

5. Kumar P, Kapoor S, Nargund V. Haematospermia: a systematic review. Ann R Coll Surg Engl. 2006; 88:339–342.

6. Raviv G, Laufer M, Miki H. Hematospermia: the added value of transrectal ultrasound to clinical evaluation: is transrectal ultrasound necessary for evaluation of hematospermia? Clin Imaging. 2013; 37:913–916.

7. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, Nickel JC, Calhoun EA, Pontari MA, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999; 162:369–375.

8. Nguyen CT, Shoskes DA. Evaluation of the prostatitis patient. In : Shoskes DA, editor. Chronic prostatitis/chronic pelvic syndrome. Totowa, NJ: Humana Press;2008. p. 1–16.

9. Nickel JC, Shoskes D, Wang Y, Alexander RB, Fowler JE Jr, Zeitlin S, et al. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol. 2006; 176:119–124.

10. Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol. 1968; 5:492–518.

11. Park H, Sim SM, Lee G. The presence of Chlamydia is associated with increased leukocyte counts and pain severity in men with chronic pelvic pain syndrome. Urology. 2015; 85:574–579.

12. Seo Y, Lee G. Antimicrobial resistance pattern in Enterococcus faecalis strains isolated from expressed prostatic secretions of patients with chronic bacterial prostatitis. Korean J Urol. 2013; 54:477–481.

13. Ganabathi K, Chadwick D, Feneley RC, Gingell JC. Haemospermia. Br J Urol. 1992; 69:225–230.

14. Jones DJ. Haemospermia: a prospective study. Br J Urol. 1991; 67:88–90.

15. Mulhall JP, Albertsen PC. Hemospermia: diagnosis and management. Urology. 1995; 46:463–467.

16. Bamberger E, Madeb R, Steinberg J, Paz A, Satinger I, Kra-Oz Z, et al. Detection of sexually transmitted pathogens in patients with hematospermia. Isr Med Assoc J. 2005; 7:224–227.

17. Araújo RS, Guimarães EM, Alves MF, Sakurai E, Domingos LT, Fioravante FC, et al. Prevalence and risk factors for Chlamydia trachomatis infection in adolescent females and young women in central Brazil. Eur J Clin Microbiol Infect Dis. 2006; 25:397–400.

18. Mazzoli S. Conventional bacteriology in prostatitis patients: microbiological bias, problems and epidemiology on 1686 microbial isolates. Arch Ital Urol Androl. 2007; 79:71–75.

19. Sood S, Malhotra M, Das BK, Kapil A. Enterococcal infections & antimicrobial resistance. Indian J Med Res. 2008; 128:111–121.

20. Schaeffer AJ. Epidemiology and demographics of prostatitis. Andrologia. 2003; 35:252–257.

21. Calhoun EA, Duloy AMS, Quentin Clemens J. Quality of life and economic impact of chronic prostatitis. In : Shoskes DA, editor. Chronic prostatitis/chronic pelvic syndrome. Totowa, NJ: Humana Press;2008. p. 59–75.